the effect of sodium valproate 1200 mg daily on the disability of parkinsonism and on levodopa-induced dyskinesia was assessed in a double-blind crossover trial with matched placebo in 12 patients with parkinson 's disease .
C0023570
levodopa
C0030567
parkinson 's disease